# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001601830-24-000148
Filing Date
2024-09-03
Accepted
2024-09-03 08:01:53
Documents
111
Period of Report
2024-09-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | rxrx-20240903.htm iXBRL | 8-K | 505733
2 | EX-23.1 | exhibit231pwcconsent.htm | EX-23.1 | 2287
3 | EX-99.1 | exhibit991-rxrxsept2024.htm | EX-99.1 | 105873
4 | EX-99.2 | exhibit992-rxrxpressrelease.htm | EX-99.2 | 16273
5 | EX-99.3 | exhibit993-exaiyefinancials.htm | EX-99.3 | 1222143
6 | EX-99.4 | exhibit994-exaiq2financials.htm | EX-99.4 | 543064
7 | EX-99.5 | exhibit995-proformadraft09.htm | EX-99.5 | 443449
11 |  | exhibit991-rxrxsept2024001.jpg | GRAPHIC | 218144
12 |  | exhibit991-rxrxsept2024002.jpg | GRAPHIC | 292374
13 |  | exhibit991-rxrxsept2024003.jpg | GRAPHIC | 190590
14 |  | exhibit991-rxrxsept2024004.jpg | GRAPHIC | 51147
15 |  | exhibit991-rxrxsept2024005.jpg | GRAPHIC | 161403
16 |  | exhibit991-rxrxsept2024006.jpg | GRAPHIC | 128768
17 |  | exhibit991-rxrxsept2024007.jpg | GRAPHIC | 135432
18 |  | exhibit991-rxrxsept2024008.jpg | GRAPHIC | 43196
19 |  | exhibit991-rxrxsept2024009.jpg | GRAPHIC | 119157
20 |  | exhibit991-rxrxsept2024010.jpg | GRAPHIC | 117150
21 |  | exhibit991-rxrxsept2024011.jpg | GRAPHIC | 157067
22 |  | exhibit991-rxrxsept2024012.jpg | GRAPHIC | 111303
23 |  | exhibit991-rxrxsept2024013.jpg | GRAPHIC | 129506
24 |  | exhibit991-rxrxsept2024014.jpg | GRAPHIC | 143038
25 |  | exhibit991-rxrxsept2024015.jpg | GRAPHIC | 120932
26 |  | exhibit991-rxrxsept2024016.jpg | GRAPHIC | 139684
27 |  | exhibit991-rxrxsept2024017.jpg | GRAPHIC | 146817
28 |  | exhibit991-rxrxsept2024018.jpg | GRAPHIC | 42128
29 |  | exhibit991-rxrxsept2024019.jpg | GRAPHIC | 78370
30 |  | exhibit991-rxrxsept2024020.jpg | GRAPHIC | 114279
31 |  | exhibit991-rxrxsept2024021.jpg | GRAPHIC | 117314
32 |  | exhibit991-rxrxsept2024022.jpg | GRAPHIC | 126460
33 |  | exhibit991-rxrxsept2024023.jpg | GRAPHIC | 71492
34 |  | exhibit991-rxrxsept2024024.jpg | GRAPHIC | 99951
35 |  | exhibit991-rxrxsept2024025.jpg | GRAPHIC | 100273
36 |  | exhibit991-rxrxsept2024026.jpg | GRAPHIC | 121873
37 |  | exhibit991-rxrxsept2024027.jpg | GRAPHIC | 104292
38 |  | exhibit991-rxrxsept2024028.jpg | GRAPHIC | 97984
39 |  | exhibit991-rxrxsept2024029.jpg | GRAPHIC | 85563
40 |  | exhibit991-rxrxsept2024030.jpg | GRAPHIC | 83468
41 |  | exhibit991-rxrxsept2024031.jpg | GRAPHIC | 111988
42 |  | exhibit991-rxrxsept2024032.jpg | GRAPHIC | 37251
43 |  | exhibit991-rxrxsept2024033.jpg | GRAPHIC | 85626
44 |  | exhibit991-rxrxsept2024034.jpg | GRAPHIC | 122236
45 |  | exhibit991-rxrxsept2024035.jpg | GRAPHIC | 137207
46 |  | exhibit991-rxrxsept2024036.jpg | GRAPHIC | 80560
47 |  | exhibit991-rxrxsept2024037.jpg | GRAPHIC | 125220
48 |  | exhibit991-rxrxsept2024038.jpg | GRAPHIC | 92746
49 |  | exhibit991-rxrxsept2024039.jpg | GRAPHIC | 121408
50 |  | exhibit991-rxrxsept2024040.jpg | GRAPHIC | 94036
51 |  | exhibit991-rxrxsept2024041.jpg | GRAPHIC | 112379
52 |  | exhibit991-rxrxsept2024042.jpg | GRAPHIC | 106843
53 |  | exhibit991-rxrxsept2024043.jpg | GRAPHIC | 119917
54 |  | exhibit991-rxrxsept2024044.jpg | GRAPHIC | 102291
55 |  | exhibit991-rxrxsept2024045.jpg | GRAPHIC | 124163
56 |  | exhibit991-rxrxsept2024046.jpg | GRAPHIC | 89387
57 |  | exhibit991-rxrxsept2024047.jpg | GRAPHIC | 133264
58 |  | exhibit991-rxrxsept2024048.jpg | GRAPHIC | 38797
59 |  | exhibit991-rxrxsept2024049.jpg | GRAPHIC | 91395
60 |  | exhibit991-rxrxsept2024050.jpg | GRAPHIC | 180794
61 |  | exhibit991-rxrxsept2024051.jpg | GRAPHIC | 128017
62 |  | exhibit991-rxrxsept2024052.jpg | GRAPHIC | 75989
63 |  | exhibit991-rxrxsept2024053.jpg | GRAPHIC | 39781
64 |  | exhibit991-rxrxsept2024054.jpg | GRAPHIC | 86683
65 |  | exhibit991-rxrxsept2024055.jpg | GRAPHIC | 117317
66 |  | exhibit991-rxrxsept2024056.jpg | GRAPHIC | 84014
67 |  | exhibit991-rxrxsept2024057.jpg | GRAPHIC | 99412
68 |  | exhibit991-rxrxsept2024058.jpg | GRAPHIC | 110562
69 |  | exhibit991-rxrxsept2024059.jpg | GRAPHIC | 34505
70 |  | exhibit991-rxrxsept2024060.jpg | GRAPHIC | 87033
71 |  | exhibit991-rxrxsept2024061.jpg | GRAPHIC | 127899
72 |  | exhibit991-rxrxsept2024062.jpg | GRAPHIC | 47800
73 |  | exhibit991-rxrxsept2024063.jpg | GRAPHIC | 150135
74 |  | exhibit991-rxrxsept2024064.jpg | GRAPHIC | 119404
75 |  | exhibit991-rxrxsept2024065.jpg | GRAPHIC | 60187
76 |  | exhibit991-rxrxsept2024066.jpg | GRAPHIC | 58993
77 |  | exhibit991-rxrxsept2024067.jpg | GRAPHIC | 46969
78 |  | exhibit991-rxrxsept2024068.jpg | GRAPHIC | 126703
79 |  | exhibit991-rxrxsept2024069.jpg | GRAPHIC | 92384
80 |  | exhibit991-rxrxsept2024070.jpg | GRAPHIC | 126526
81 |  | exhibit991-rxrxsept2024071.jpg | GRAPHIC | 122472
82 |  | exhibit991-rxrxsept2024072.jpg | GRAPHIC | 94897
83 |  | exhibit991-rxrxsept2024073.jpg | GRAPHIC | 89998
84 |  | exhibit991-rxrxsept2024074.jpg | GRAPHIC | 116204
85 |  | exhibit991-rxrxsept2024075.jpg | GRAPHIC | 116046
86 |  | exhibit991-rxrxsept2024076.jpg | GRAPHIC | 78723
87 |  | exhibit991-rxrxsept2024077.jpg | GRAPHIC | 95815
88 |  | exhibit991-rxrxsept2024078.jpg | GRAPHIC | 86679
89 |  | exhibit991-rxrxsept2024079.jpg | GRAPHIC | 116872
90 |  | exhibit991-rxrxsept2024080.jpg | GRAPHIC | 99658
91 |  | exhibit991-rxrxsept2024081.jpg | GRAPHIC | 84481
92 |  | exhibit991-rxrxsept2024082.jpg | GRAPHIC | 93673
93 |  | exhibit991-rxrxsept2024083.jpg | GRAPHIC | 112970
94 |  | exhibit991-rxrxsept2024084.jpg | GRAPHIC | 97850
95 |  | exhibit991-rxrxsept2024085.jpg | GRAPHIC | 82517
96 |  | exhibit991-rxrxsept2024086.jpg | GRAPHIC | 118461
97 |  | exhibit991-rxrxsept2024087.jpg | GRAPHIC | 97271
98 |  | exhibit991-rxrxsept2024088.jpg | GRAPHIC | 103579
99 |  | exhibit991-rxrxsept2024089.jpg | GRAPHIC | 95930
100 |  | exhibit991-rxrxsept2024090.jpg | GRAPHIC | 116647
101 |  | exhibit991-rxrxsept2024091.jpg | GRAPHIC | 95165
102 |  | exhibit991-rxrxsept2024092.jpg | GRAPHIC | 126465
| Complete submission text file | 0001601830-24-000148.txt |  | 16854617

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rxrx-20240903.xsd | EX-101.SCH | 1907
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rxrx-20240903_lab.xml | EX-101.LAB | 21629
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rxrx-20240903_pre.xml | EX-101.PRE | 12512
113 | EXTRACTED XBRL INSTANCE DOCUMENT | rxrx-20240903_htm.xml | XML | 2745

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 241272038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)